Global Endometriosis Market Growth 2023-2029
Endometriosis is a medical condition in which the tissue that forms normal lining of uterus appears outside the uterus cavity and may involve ovaries, bowel or tissue lining of the pelvic floor.
LPI (LP Information)' newest research report, the “Endometriosis Industry Forecast” looks at past sales and reviews total world Endometriosis sales in 2022, providing a comprehensive analysis by region and market sector of projected Endometriosis sales for 2023 through 2029. With Endometriosis sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Endometriosis industry.
This Insight Report provides a comprehensive analysis of the global Endometriosis landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Endometriosis portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Endometriosis market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Endometriosis and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Endometriosis.
The global Endometriosis market size is projected to grow from US$ 1482.7 million in 2022 to US$ 1637.5 million in 2029; it is expected to grow at a CAGR of 1637.5 from 2023 to 2029.
Rising incidences of endometriosis due to diagnostic improvements leading to early identification, environmental factors, and rising awareness is the key factor contributing to growth of the market. Global endometriosis market is expected to register a healthy growth, owing to rise in awareness amongst patients and physicians. In addition, considerable research efforts towards development of novel non hormonal drugs, diagnostic and surgical techniques coupled with substantial support in terms of funding has helped to further enhance the growth of this market. Therefore, huge unmet needs for curative treatment of endometriosis will serve this market as a potential opportunity. The growth in global endometriosis market will be primarily driven by emerging Asian economies, where the disease prevalence is almost 10% of the total female population of this region.
This report presents a comprehensive overview, market shares, and growth opportunities of Endometriosis market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Gonadotropins Releasing Hormone Agonists
Non-Steroidal Anti-Inflammatory Drugs
Progestin
Oral Contraceptive Pills
Segmentation by application
Hospital Use
Clinic Use
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
AbbVie
AstraZeneca
Bayer HealthCare
Pfizer
Addex Therapeutics
Astellas Pharma
Debiopharm
ElexoPharm
EndoCeutics
Euroscreen
Forendo Pharma
Kissei Pharmaceutical
Neurocrine Biosciences
Nippon Shinyaku
Takeda
Bayer AG
Neurocrine Biosciences
Key Questions Addressed in this Report
What is the 10-year outlook for the global Endometriosis market?
What factors are driving Endometriosis market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Endometriosis market opportunities vary by end market size?
How does Endometriosis break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Please note: The report will take approximately 2 business days to prepare and deliver.